PAPER Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME
SEARCH RESULTS
340467 RESULTS
PAPER von Bernhardi R, Ramirez G
Microglia-astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system?
Biol Res. 2001;34(2):123-8. PubMed.PAPER Jiang S, Lin S, Tang G
[The association between microsatellite polymorphism of alpha 1-antichymotrypsin gene and Alzheimer's disease].
Zhonghua Yi Xue Za Zhi. 1999 Aug;79(8):610-2. PubMed.PAPER Lee BF, Liu CK, Tai CT, Chiu NT, Liu GC, Yu HS, Pai MC
Alzheimer's disease: scintigraphic appearance of Tc-99m HMPAO brain spect.
Kaohsiung J Med Sci. 2001 Aug;17(8):394-400. PubMed.PAPER Maruyama M, Arai H, Sugita M, Tanji H, Higuchi M, Okamura N, Matsui T, Higuchi S, Matsushita S, Yoshida H, Sasaki H
Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease.
Exp Neurol. 2001 Dec;172(2):433-6. PubMed.PAPER Wong A, Lüth HJ, Deuther-Conrad W, Dukic-Stefanovic S, Gasic-Milenkovic J, Arendt T, Münch G
Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.
Brain Res. 2001 Nov 30;920(1-2):32-40. PubMed.PAPER Bradbury J
New mechanism proposed for NSAID reduction of Alzheimer's disease incidence.
Lancet. 2001 Nov 10;358(9293):1616. PubMed.PAPER Hashimoto Y, Niikura T, Ito Y, Sudo H, Hata M, Arakawa E, Abe Y, Kita Y, Nishimoto I
Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults.
J Neurosci. 2001 Dec 1;21(23):9235-45. PubMed.PAPER Shiozaki K, Iseki E, Hino H, Kosaka K
Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study.
J Neurol Sci. 2001 Dec 15;193(1):23-8. PubMed.PAPER Annaert WG, Esselens C, Baert V, Boeve C, Snellings G, Cupers P, Craessaerts K, De Strooper B
Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins.
Neuron. 2001 Nov 20;32(4):579-89. PubMed.PAPER Kagan BL, Hirakura Y, Azimov R, Azimova R
The channel hypothesis of Huntington's disease.
Brain Res Bull. 2001 Oct-Nov 1;56(3-4):281-4. PubMed.Dominic Walsh on Fog Beginning to Clear on Aβ-Degrading Enzymes?
COMMENT Aβ-degrading enzymes—many candidates, but few fit the bill This comment extends the news report filed directly from the meeting to provide a more detailed description of this emerging area. To date, a number of potential Aβ-degrading enzymes have been ide
Society for Neuroscience Annual Meeting 2001
CONFERENCE COVERAGE SERIES Post-Conference News: Oligomers, Protofibrils, and Fibrils—They Are All Bad Post-Conference News: Fly-Fishing for γ-Secretase Function and Substrates Society for Neuroscience Annual Meeting 2001
Post-Conference News: Fly-Fishing for γ-Secretase Function and Substrates
CONFERENCE COVERAGE 2001-11-20 Conference Coverage A number of presentations at this year's Society for Neuroscience meeting provided new insight into the biology of presenilin. First, about its function. Deletion of the notch receptor in Drosophila produces a characteristic, hypo
Post-Conference News: Oligomers, Protofibrils, and Fibrils—They Are All Bad
CONFERENCE COVERAGE 2001-11-20 Conference Coverage Extensive data supporting a central role for Aβ in the genesis of Alzheimer's disease notwithstanding, the amyloid hypothesis has its weaknesses. One is that a specific neurotoxic Aβ species and the nature of its effects on neuron
Current Filters
No filters selected